Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Solventum Corp. (SOLV)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: SOLV (2-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
12 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $86.71
1 Year Target Price $86.71
| 1 | Strong Buy |
| 2 | Buy |
| 8 | Hold |
| 1 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 9.8% | Avg. Invested days 55 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 08/28/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 12.60B USD | Price to earnings Ratio 33.33 | 1Y Target Price 86.71 |
Price to earnings Ratio 33.33 | 1Y Target Price 86.71 | ||
Volume (30-day avg) 12 | Beta - | 52 Weeks Range 60.70 - 85.92 | Updated Date 08/29/2025 |
52 Weeks Range 60.70 - 85.92 | Updated Date 08/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 2.18 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Revenue by Geography
Earnings Date
Report Date 2025-08-07 | When - | Estimate 1.68 | Actual 1.69 |
Profitability
Profit Margin 4.53% | Operating Margin (TTM) 9.26% |
Management Effectiveness
Return on Assets (TTM) 3.52% | Return on Equity (TTM) 11.67% |
Valuation
Trailing PE 33.33 | Forward PE 12.36 | Enterprise Value 19921357402 | Price to Sales(TTM) 1.5 |
Enterprise Value 19921357402 | Price to Sales(TTM) 1.5 | ||
Enterprise Value to Revenue 2.38 | Enterprise Value to EBITDA 15.61 | Shares Outstanding 173388000 | Shares Floating 147506201 |
Shares Outstanding 173388000 | Shares Floating 147506201 | ||
Percent Insiders 14.88 | Percent Institutions 66.72 |
Upturn AI SWOT
Solventum Corp.
Company Overview
History and Background
Solventum Corp. was spun off from 3M on April 1, 2024. As part of 3M's health care business, it has a long history of innovation and expertise in medical solutions.
Core Business Areas
- Medical Solutions: This segment includes wound care, infection prevention, sterilization, and other medical products used in hospitals and healthcare facilities.
- Oral Care Solutions: This segment focuses on dental and orthodontic products, including dental restoratives, adhesives, and aligners, sold to dental professionals and consumers.
- Purification: This segment provides filtration and purification solutions for various industries including pharmaceutical, food and beverage, and industrial applications.
- Separation and Purification: This segment focuses on separations and purification technologies for the pharmaceutical and biopharmaceutical industries.
Leadership and Structure
Bryan Hanson is the CEO of Solventum. The company operates with a divisional structure aligned to its core business areas. Board members are available at solventum.com/page/leadership
Top Products and Market Share
Key Offerings
- Wound Care Products: Solventum offers a wide range of wound care dressings, tapes, and cleansers used in hospitals and clinics. Market share data is difficult to ascertain immediately post spin-off but 3M healthcare had significant market share in this category. Competitors include Smith & Nephew, Convatec, and Medline Industries.
- Dental Adhesives and Restoratives: Solventum produces dental adhesives, restoratives, and impression materials used by dentists. Market share data is difficult to ascertain immediately post spin-off but 3M healthcare had significant market share in this category. Competitors include Dentsply Sirona, Envista Holdings, and Ivoclar Vivadent.
- Filtration Products: Solventum manufactures filtration technologies for food, water, beverage and pharmaceutical industries. Market share data is difficult to ascertain immediately post spin-off but 3M healthcare had significant market share in this category. Competitors include Pall Corporation, Sartorius, and Danaher.
Market Dynamics
Industry Overview
The healthcare industry is experiencing growth due to an aging population, increased demand for medical devices and technologies, and advances in medical science. The filtration industry continues to grow due to clean water demands and regulatory needs in several industries.
Positioning
Solventum is positioned as a provider of innovative healthcare and filtration solutions with a focus on quality, reliability, and customer service. It aims to maintain a competitive edge through product innovation and market expansion.
Total Addressable Market (TAM)
The global healthcare market is estimated to be worth trillions of USD and the filtration market is around 80B USD, with Solventum aiming to capture a significant portion through its diverse product portfolio.
Upturn SWOT Analysis
Strengths
- Established brand reputation from 3M
- Diverse product portfolio
- Strong distribution network
- History of innovation
- High profit margins in select business segments.
Weaknesses
- Newly independent company
- Reliance on 3M for certain services initially
- Uncertainties regarding long-term debt load.
- Potential for market perception shift due to spin-off
- Integration challenges post spin-off
Opportunities
- Expand into emerging markets
- Develop new and innovative products
- Acquire complementary businesses
- Increase focus on digital health solutions
- Capitalize on growing demand for personalized medicine.
Threats
- Increased competition
- Regulatory changes
- Economic downturns
- Technological obsolescence
- Patent expirations.
Competitors and Market Share
Key Competitors
- DHR
- MMM
- SYK
- BSX
- ABT
Competitive Landscape
Solventum benefits from its reputation, established products, and large potential market share. Solventum's disadvantages include starting as a new company and uncertainties regarding its debt load.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data is tied to the 3M healthcare segment.
Future Projections: Future growth projections will depend on Solventum's ability to innovate, expand into new markets, and manage its costs effectively.
Recent Initiatives: Recent initiatives include establishing the company as a standalone entity, defining its corporate strategy, and building its own infrastructure.
Summary
Solventum, recently spun off from 3M, possesses a strong foundation built on its established product lines and history of innovation. The company's success will depend on its ability to navigate its newfound independence, manage its debt, and capitalize on growth opportunities in the healthcare and filtration industries. Solventum's competitive advantages rest on its established products and strong distribution network, it needs to keep an eye on integration challenges post spin-off. Regulatory and competition need to be monitered to maintain a successful growth model.
Peer Comparison
Sources and Disclaimers
Data Sources:
- 3M SEC Filings
- Solventum Investor Relations
- Market Research Reports
- Analyst Reports
Disclaimers:
This analysis is based on available information and assumptions, and is not financial advice. Investors should conduct their own due diligence.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Solventum Corp.
Exchange NYSE | Headquaters Maplewood, MN, United States | ||
IPO Launch date 2024-03-26 | CEO & Director Mr. Bryan C. Hanson | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 22000 | Website https://www.solventum.com |
Full time employees 22000 | Website https://www.solventum.com | ||
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wrap, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. Its Dental Solutions segment provides a suite of dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions and services for health care systems, such as computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. Its Purification and Filtration segment provides purification and filtration technologies comprising filters, purifiers, cartridges, and membranes. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is based in Maplewood, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.